Published

166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Biological Psychiatry
Date: 2025-04-09
Source: OpenAlex
DOI: 10.1016/j.biopsych.2025.02.403
PubMed: Unavailable

Authors

Xue Zhang Emily Zhai Claire Bertrand Sara Ellis Isabelle Wydler Anna J. Donnelly Trisha Suppes Leanne M. Williams

Watch author

Derived topics and classifications

psilocybin Depression Treatment-Resistant Depression Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression2025-04-09

Related papers

The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-26 Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-22 194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-09 186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-09 Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted PsychotherapyAnnals of Punjab Medical College · 2024-12-31 A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in DepressionUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2026-07-27 Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17 Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted TherapiesThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · 2026-03-16